All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
This Treg population is obtained by ex vivo expansion of nTreg (Tregs isolated directly from blood). The expanded nTregs show the classical regulatory T cell phenotype, i.e., CD4+, CD25hi, and CD127-. In addition, the majority of the cells show intracellular expression of FoxP3 and surface expression of TIGIT. These nTregs also have the capacity to suppress in vitro T cell proliferation (e.g., anti-CD3 driven or MLR).
There are currently no customer reviews or questions for Expanded nTreg, Donor 287 (ICZP178). Click the button below to contact us or submit your feedback about this product.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION